MTCO3P44

Across TCGA pan-cancer cohorts, MTCO3P44 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MTCO3P44 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MTCO3P44 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO3P44 expression acts as an unfavorable survival marker, although some lineages such as LUAD and THCA show a favorable association.

UCS, THYM, and LUSC are the cancer types where MTCO3P44 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.078	0.648	<.001	108	view →
THYM	OS	Tertile	All	0.826	0.982	<.001	90	view →
LUSC	DFS	Tertile	III,IV	0.123	0.780	<.001	81	view →
UVM	OS	Tertile	II,III,IV	0.218	0.718	.006	72	view →
LUAD	OS	Tertile	All	0.426	0.311	.011	45	view →
LAML	DFS	Median	All	0.446	0.686	<.001	42	view →
LIHC	OS	Tertile	II,III,IV	0.079	0.771	.002	36	view →
MESO	OS	Tertile	III,IV	0.314	0.598	.001	27	view →
LGG	OS	Tertile	All	0.668	0.823	.001	27	view →
CHOL	OS	Tertile	All	0.237	0.711	.001	18	view →
THCA	DFS	Tertile	All	1.000	0.756	.016	15	view →
STAD	OS	Tertile	II,III,IV	0.680	0.399	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MTCO3P44–UCS (OS)

Open the UCS breakdown →